BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8333959)

  • 21. Germline transmission and efficient DNA recombination in mouse embryonic stem cells mediated by adenoviral-Cre transduction.
    Shui JW; Tan TH
    Genesis; 2004 Jul; 39(3):217-23. PubMed ID: 15282749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of PDE4 knockout mice by gene targeting.
    Jin SL; Latour AM; Conti M
    Methods Mol Biol; 2005; 307():191-210. PubMed ID: 15988065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency electromagnetic fields (GSM signals) affect gene expression levels in tumor suppressor p53-deficient embryonic stem cells.
    Czyz J; Guan K; Zeng Q; Nikolova T; Meister A; Schönborn F; Schuderer J; Kuster N; Wobus AM
    Bioelectromagnetics; 2004 May; 25(4):296-307. PubMed ID: 15114639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPSS profiling of human embryonic stem cells.
    Brandenberger R; Khrebtukova I; Thies RS; Miura T; Jingli C; Puri R; Vasicek T; Lebkowski J; Rao M
    BMC Dev Biol; 2004 Aug; 4():10. PubMed ID: 15304200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ES cell technology: an introduction to genetic manipulation, differentiation and therapeutic cloning.
    Hook L; O'Brien C; Allsopp T
    Adv Drug Deliv Rev; 2005 Dec; 57(13):1904-17. PubMed ID: 16253387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of p53 by RNAi in ES cells facilitates RA-induced differentiation into muscle cells.
    He Z; Li J; Zhen C; Feng L; Ding X
    Biochem Biophys Res Commun; 2005 Sep; 335(3):676-83. PubMed ID: 16087156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering embryonic stem cell derived glia for adenosine delivery.
    Fedele DE; Koch P; Scheurer L; Simpson EM; Möhler H; Brüstle O; Boison D
    Neurosci Lett; 2004 Nov; 370(2-3):160-5. PubMed ID: 15488315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells.
    Wiles MV; Vauti F; Otte J; Füchtbauer EM; Ruiz P; Füchtbauer A; Arnold HH; Lehrach H; Metz T; von Melchner H; Wurst W
    Nat Genet; 2000 Jan; 24(1):13-4. PubMed ID: 10615117
    [No Abstract]   [Full Text] [Related]  

  • 29. Mouse embryonic stem cells express receptors of the insulin family of growth factors.
    Shi CZ; Dhir RN; Kesavan P; Zhang SL; Matschinsky FM; Heyner S
    Mol Reprod Dev; 1995 Oct; 42(2):173-9. PubMed ID: 8562062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation.
    Eggan K; Rode A; Jentsch I; Samuel C; Hennek T; Tintrup H; Zevnik B; Erwin J; Loring J; Jackson-Grusby L; Speicher MR; Kuehn R; Jaenisch R
    Nat Biotechnol; 2002 May; 20(5):455-9. PubMed ID: 11981557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a novel mouse tk+/- embryonic stem cell line for use in mutagenicity studies.
    Dobrovolsky VN; Casciano DA; Heflich RH
    Environ Mol Mutagen; 1996; 28(4):483-9. PubMed ID: 8991081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes.
    Yang Y; Seed B
    Nat Biotechnol; 2003 Apr; 21(4):447-51. PubMed ID: 12627171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene.
    Snouwaert JN; Gowen LC; Latour AM; Mohn AR; Xiao A; DiBiase L; Koller BH
    Oncogene; 1999 Dec; 18(55):7900-7. PubMed ID: 10630642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells.
    Beard C; Hochedlinger K; Plath K; Wutz A; Jaenisch R
    Genesis; 2006 Jan; 44(1):23-8. PubMed ID: 16400644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput site-directed mutagenesis in ES cells.
    Höllrigl A; Hergovich A; Görzer I; Bader A; Ellersdorfer G; Habegger K; Hammer E; Enzinger S; Capetanaki Y; Weitzer G
    Biochem Biophys Res Commun; 2001 Nov; 289(2):329-36. PubMed ID: 11716476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells.
    Willems E; Mateizel I; Kemp C; Cauffman G; Sermon K; Leyns L
    Int J Dev Biol; 2006; 50(7):627-35. PubMed ID: 16892176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells.
    Guo G; Wang W; Bradley A
    Nature; 2004 Jun; 429(6994):891-5. PubMed ID: 15215866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for homologous recombination in ES cells using RT-PCR.
    Danoff TM; Chiang M; Jänne PA; Neilson EG
    Biotechniques; 1997 Jan; 22(1):22-4, 26. PubMed ID: 8994638
    [No Abstract]   [Full Text] [Related]  

  • 39. Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells.
    Cerdan C; Bendall SC; Wang L; Stewart M; Werbowetski T; Bhatia M
    Nat Med; 2006 Oct; 12(10):1113-4; author reply 1115. PubMed ID: 17024197
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene targeting at the chromosomal immunoglobulin locus: a model system for the study of mammalian homologous recombination mechanisms.
    Baker MD
    Methods Mol Biol; 2004; 262():143-55. PubMed ID: 14769960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.